About The Webinar
This webinar begins with an introduction to ‘Cutaneous and renal Glomerular Vasculopathy’ (CRGV) including terminology. The pathogenesis of the illness as a thrombotic microangiopathy (TMA) is covered, followed by a brief history of thrombotic microangiopathies in veterinary species.
Thereafter, we move on to describe the signalment and epidemiology of CRGV cases, followed by the typical clinical signs, including some photograph examples of the range of skin lesions seen.
Previous research into the underlying aetiology is summarised, before moving onto the approach to suspected cases. Laboratory findings and ways to monitor non-azotaemic, and approach azotaemic, cases is then detailed, followed by a brief refresher about acute kidney injury (AKI) and the IRIS grading system for this.
The management for suspected azotaemic CRGV cases is covered, including how to calculate appropriate fluid therapy in the setting of AKI. Management of oligoanuria, including peritoneal dialysis and continuous renal replacement therapy (CRRT) follows on from this.
Dermal and renal histopathology findings are discussed, before moving on to a comparison between the disease in racing greyhounds in the USA, and a brief summary of human TMA illnesses, including how these are guiding current research. Further resources and reading are listed, before a final summary of the disease and current knowledge, completes the webinar.
